RPL554
Jump to navigation
Jump to search
Indications
Mechanism of action
- PDE3 inhibitor & PDE4 inhibitor
- may diminish bronchospasm & inflammation
More general terms
References
- ↑ Franciosi LG et al Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. Lancet Respir Med, 25 October 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24429275 <Internet> http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)70187-5/abstract